Vagistat® vs Monistat®: What Should I Use To Treat My Vaginal Yeast Infection?

This is not medical advice and is for informational purposes only. Please seek out your medical provider before engaging in any of these treatments.

Vaginal yeast infections are incredibly common, with up to 75% of women experiencing at least one in their lifetime. These infections are caused by an overgrowth of Candida, a yeast that is naturally present in many parts of the body, including the vaginal area. The natural balance of the vagina can be disrupted by various factors, such as antibiotics, pregnancy, or hormonal changes, leading to the uncomfortable symptoms of a yeast infection, like itching, burning, and changes in discharge.

When it comes to treating a vaginal yeast infection, two well-known over-the-counter options are often mentioned: Vagistat and Monistat. Both products offer effective relief, but what sets them apart? Let’s break down the similarities and differences between these two antifungal treatments.

Active Ingredient: The Same, But the Price Is Different

Both Monistat and Vagistat sell anti-fungal treatments that use miconazole as their active antifungal ingredient. Miconazole works by disrupting the cell membrane of the Candida yeast, preventing its growth and ultimately clearing the infection.

According to research, miconazole has been proven to effectively treat vaginal yeast infections by killing the overgrown yeast, reducing the symptoms such as itching, burning, discharge and inflammation. Though the active ingredient and dosage are the same, Vagistat offers a more budget-friendly option compared to Monistat, providing an affordable solution without sacrificing effectiveness.

While both brands are well-established names in the market, Vagistat’s lower price point makes it a more accessible choice for many women, especially those who need to manage their healthcare expenses.

Variety and Flexibility in Treatment Length

Just like Monistat, Vagistat offers a range of treatment options, allowing users to choose between a 7-day, 3-day or even a 1-dose course of treatment.

Vagistat® 1 Day is a great option for those who want to treat in a single dose. Vagistat 3 and 7 day are great options for those who want to treat in more moderate, consistent dosage levels. The Vagistat 7 day contains the smallest dose of active ingredient evenly distributed each day at bedtime. Additionally, the CDC recommends a 7 day treatment for pregnant and diabetic women. 

• All Vagistat treatments should be used as directed.
• All Vagistat products can take up to 7 days to fully cure a yeast infection.

Proven Effectiveness for Relief

The active ingredients used by both brands have been clinically proven to be effective in treating vaginal yeast infections. When it comes to choosing between Monistat and Vagistat brands, effectiveness is not an issue, as both deliver results. Miconazole’s role in treating vaginal yeast infections is widely accepted in the medical community. It targets the growth of Candida and helps restore the balance of the vaginal flora, allowing the body to heal naturally.

In some cases, yeast infections can be complicated or recurrent, especially in individuals with weakened immune systems, diabetes, or during pregnancy. For these cases, consult a doctor or healthcare professional to discuss treatment options. As noted by experts, some severe or recurrent infections may require a more tailored approach, but both Monistat and Vagistat are proven to be reliable first-line treatments.

Side Effects and Safety

Like all medications, both Monistat and Vagistat can cause mild side effects, including irritation, itching, or burning around the vaginal area. These side effects are usually temporary and should subside as the infection clears. However, more serious side effects, such as an allergic reaction, fever, or foul-smelling discharge, although rare, may require medical attention.

Both products are considered safe for most women, but it’s important to consult with a healthcare provider if you have never had a vaginal yeast infection diagnosed by a doctor or if you experience any unusual or worsening symptoms. While studies have shown that the active ingredients used in both Vagistat and Monistat are safe to use when pregnant, consult your doctor for more information.

Affordability: Vagistat’s Competitive Advantage

We think one of the best reasons to opt for Vagistat over Monistat is its affordability. While both brands use miconazole and offer similar results, Vagistat is more cost-effective, making it a more accessible choice for women treating their yeast infections.

By choosing Vagistat, women can save money without compromising on the quality or effectiveness of their treatment. By offering our products at a fairer price, we can make a significant difference for customers, allowing them to receive the same trusted antifungal treatment at a lower price.

Ease of Use and Availability

Both Monistat and Vagistat are available over-the-counter without a prescription. Whether you’re familiar with either brand or trying one for the first time, both products come with clear, user-friendly instructions, ensuring a straightforward and convenient treatment experience.

A Smarter, More Affordable Choice

While Monistat is a widely recognized name in the world of vaginal yeast infection treatments, Vagistat offers a smarter, more affordable alternative. Both products share the same active ingredient - miconazole which has been proven in clinical studies to effectively treat vaginal yeast infections. The key difference lies in the price, with Vagistat offering the same treatment for less. Use Vagistat to manage yeast infections and get back to feeling like yourself again.

Always consult with a healthcare provider if have never had a vaginal yeast infection diagnosed by a doctor or if you’re uncertain about your symptoms or treatment options, especially if you have recurrent infections or underlying health conditions.

References:
https://my.clevelandclinic.org/health/diseases/5019-vaginal-yeast-infection 
https://pmc.ncbi.nlm.nih.gov/articles/PMC1045744/pdf/brjvendis00026-0043.pdf 
https://www.ajog.org/article/0002-9378(74)90348-2/abstract
https://www.sciencedirect.com/science/article/abs/pii/S0889854521003776